Emma J. Harrell

Most-cited papers

1. Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers

   Ronnatrai Rueangweerayut, G. Bancone, Emma J. Harrell, A. Beelen +13 more

   2017American Journal of Tropical Medicine and Hygiene103 citations Open access

   Semantic Scholar

   Save

2. Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects.

   Ann K. Miller, Emma J. Harrell, L. Ye, S. Baptiste-Brown +9 more

   2013British Journal of Clinical Pharmacology53 citations Open access

   Semantic Scholar

   Save

3. Tafenoquine at therapeutic concentrations does not prolong fridericia-corrected QT interval in healthy subjects

   J. Green, Apurva K. Patel, B. Patel, Azra Hussaini +6 more

   2014Journal of clinical pharmacology35 citations Open access

   Semantic Scholar

   Save

4. Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria.

   A. Tiono, A. Dicko, D. Ndububa, T. Agbenyega +10 more

   2009American Journal of Tropical Medicine and Hygiene31 citations Open access

   Semantic Scholar

   Save

5. Chlorproguanil-Dapsone-Artesunate Vs. Chlorproguanil-Dapsone: A Randomised, Double-Blind Phase Iii Trial for the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria

   A. Tiono, A. Dicko, D. A. Nclububa, T. Abenyega +10 more

   20082 citations

   Semantic Scholar

   Save